GeneReach

GeneReach provides world's leading cost-effective CE-marked IVD products for nucleic acid detection to aid timely disease diagnosis:
1. POCKIT Central Nucleic Acid Analyzer (CE-IVD)
2. POCKIT Micro Series Nucleic Acid Analyzer (CE-IVD)
3. Human IVD PCR Assays (CE-IVD)
◆ POCKIT Central C. difficile
◆ POCKIT Central Norovirus
◆ POCKIT Dengue Virus Reagent Set
4. taco/taco mini Nucleic Acid Automatic Extraction System (CE-IVD)
5. taco Preloaded DNA/RNA Extraction Reagent Set (CE-IVD)

Genetech Biotech Co., Ltd

Genetech Biotech Co. Ltd. distributes illumina NGS system, bioinformatics solution, and circulating tumor cell (CTC) enrichment related products, also offers assistance for genomic analysis, specialized technical support, users\' training, and installation/maintenance of distributing hardware.

By providing efficient and professional service of genomic and cell biology equipment, we devote our efforts to Taiwan’s biotechnology with professional knowledge and consistent enthusiasm.

Genetics Generation Advancement Corporation

The Genetics Generation Advancement Corporation under the BIONET Corporation focuses on 5 major areas in precision medicine: maternal-fetal medicine, pediatric diseases, companion diagnostics, cancer screening, and precision health management. The company also expands its expertise and applies to consumer’s market with clinical standards by releasing diverse genetic testing for all ages, which combines big data analysis of biological information and connects with national medical plans to provide a complete, innovative, and integrated service.
First place achievements:
▸ The first listed company at stock exchange market specializing in genetic testing and scientific informatics in Taiwan.
▸ The first company in Taiwan that releases genetic testing for spinal muscular atrophy (SMA), second trimester maternal serum screening of 4 indexes for Down syndrome, and pre-implantation genetic diagnosis (PGD, UltraPGD).
▸ The first laboratory in Taiwan that received accreditation by College of American Pathologists (CAP), Taiwan Accreditation Foundation (TAF), Affymetrix®, and Illumina® CSPro, and passed test for hepatitis C virus NS5A mutation analysis by Taiwanese Society of Molecular Medicine.
Outstanding developments:
▸ Serving 40% of newborn babies in Taiwan each year.
▸ Establishing over 1.2 million pieces of medical big data.
▸ Testing services that encompass 11 countries over continents of Asia, Europe, and America.
▸ Cooperation with over 100 institutes from industry, government, academia, and research.
▸ Cooperation with 95% of domestic pregnancy testing facilities and many professional testing institutes.
▸ The first to establish a genetic counseling team that integrates genetic testing to provide genetic medical services.
▸ The first to introduce SNP chips to expand prenatal screening to pediatric disease diagnosis.
▸ The first to form a NIPT team with Natera (USA) and Berry Genomics (China) to provide complete prenatal testing services.
▸ Spending millions of dollars each year to help reporting abnormal fetuses and provide free microarray comparisons of parental blood to further clarify the risk.

GenoRx Co., Ltd.

－NGS service
－Microbio-CRS
－GIANT Microbes
－GenoHealth
－MicrobioRx

GRAND MARQUIS CO., LTD

Medical supplies

Health GeneTech Corp.

Health GeneTech lab is certificated by ISO17025-preventive medicine laboratory, Illumina Certified Service Provider and the third-generation sequencing Nanopore Certified Service Provider.
Provide the service of Precision Healthcare:
●The Risk of Diseases: Genetic testing for understanding the risk of diseases, to get away from risk factors, and choose the right lifestyle.
●Gut Microbiota Monitoring: By detecting the distribution of gut bacteria, to understand the possibility of getting intestinal disease, as an indicator to improve your physiology.
●Noninvasive colon cancer screening test: Screening for the risk of colorectal cancer through noninvasive fecal genetic testing for early detection and early treatment. (use the detection kit approved by FDA and CFDA)

immuno Genomics Co., Ltd

Immune repertoire sequencing service
> T Cell Receptor (TCR) Sequencing & analysis
> B Cell Receptor (BCR) Sequencing & analysis
> Single T cell receptors (alpha & beta) pair analysis

Institute of Stem Cell Therapy

Institute of Stem Cell Therapy from the capital of Ukraine, Kyiv provides professional fetal stem cell treatment. Now Institute of Stem Cell clinic has got two modern clinic and high equipped laboratory and a cryobank. It is the only clinic certified by Ministry of Health of Ukraine and has European ISO certificate. Our scientists have got more than 40 years of experience in developing stem cells and 250 authorized patents. More than 8000 people from all over the world including Europe, Middle East, USA, Canada, China visited our clinic for stem cell treatment.

Lukas Biomedical Inc.

Lukas is dedicated the research of Memory T cell (LuLym-T®) to improve clinical outcome of cancer treatment.
All Immunotherapy technologies developed by Lukas adhere to the highest principles:
- T cell: Our QC team ensure that all memory T cells are cultured to an amount of 10^9～10^10 with purity of more than 95%.
- Timing: Lukas has been cooperating with hospitals to develop different protocols for different cancers to ensure that all cells are administered at the most suitable time during conventional treatments.
- Testament: Evidence-based medicine has been published in the international medical journals.
- GTP：All our cells are cultured in GTP labs with world-class standards to ensure the highest safety standards.

Lukas`s T cell technology has been published in the international medical journals: Lancet and Gastroenterology. The results of two studies showed that immunotherapy could significantly lower duration of cancer recurrence and increase survival rate.

Mao Ying Genetech Inc.

A multi-purposed cancer diagnostics

An accurate diagnosis for cancer is a must for the subsequent treatment design. However, the traditional cancer diagnosis which is based on a subjective judgment on the image of the biopsy may sometimes cause confusions.
We have developed an objective, multi-purposed molecular diagnostic system for cancers through analyzing a big volume of gene expression data with our proprietary algorithm. The validations by our markers could reach up to 100% for accuracies and were high in sensitivities and specificities.
The outcome of the tests could provide physicians molecular basis of pathology in addition to the information to assist diagnosis.
Based on the mRNA portrait of the biopsy specimen, our cancer diagnosis system could provide the following answers in one test:
• To identify the primary site of a metastatic cancer
• To distinguish benign tumors from malignant
• To tell cancer malignancy of a tumor specimen
• To perform cancer subtyping
More functions are under development
• IHC marker selector (under development)
• Prognosis prediction (under development)
• Companion diagnosis for selected drugs (in plan, collaboration is welcome)
Note: Our markers have been tested on microarrays and magnetic beads with reliable results.